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Early research on sepsis has focused on the initial hyper-inflammatory, cytokine
mediated phase of the disorder whereas the events that govern the concomitant and
subsequent anti-inflammatory compensatory response are not completely understood.
In this context, the putative participation of TNFR1-mediated signaling in the
immunosuppressive phase of Staphylococcus aureus sepsis has not been elucidated.
The aim of this study was to determine the role of TNFR1 in directing the immune
dysfunction during S. aureus sepsis and the potential contribution of MDSC to
this process. Using a model of sepsis of peritoneal origin and tnfr1−/− mice, we
demonstrated that during staphylococcal sepsis CD4+ T cell anergy is significantly
dependent on TNFR1 expression and that signaling through this receptor has an impact
on bacterial clearance in the spleen. MDSC played a major role in the generation of
anergic CD4+ T cells and their accumulation in the spleen during S. aureus sepsis
correlated with IL-6 induction. Although TNFR1 signaling was not required for MDSC
accumulation and expansion in the spleen, it determined the in vivo expression of
Arginase 1 and iNOS, enzymes known to participate in the suppressive function of this
population. Moreover, our data indicate that TNFR1-mediated IL-10 production may
modulate MDSC function during staphylococcal sepsis. Taken together these results
indicate that TNFR1 plays a critical role on T cell dysfunction during S. aureus sepsis
by regulating immunomodulatory mediators in MDSC. The role of TNFR1-mediated
signaling during the immunosuppressive phase of staphylococcal sepsis should be
considered when designing novel alternative therapeutic approaches.
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INTRODUCTION
Sepsis is a major public health issue and despite improved patient management and supportive
care it remains as the leading cause of death in the intensive care units with an estimation of 15–30
million cases worldwide every year (Adhikari et al., 2010; Mayr et al., 2014; Delano and Ward,
2016; Fleischmann et al., 2016) and an incidence of 450 per 100,000 inhabitants (Fleischmann
et al., 2016) with nearly 20% mortality rate. The etiology of sepsis has been changing over the last
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decades with a raising incidence of the gram positive cocci
Staphylococcus aureus (Sampedro and Bubeck Wardenburg,
2017). The origin of sepsis can be related to hospital interventions
as well as to complications of community-acquired infections
that become invasive. In this context, the high incidence of
methicillin resistant isolates, from hospital and community
environments, have added complexity to the situation.
Early research on sepsis has focused on the initial hyper-
inflammatory, cytokine mediated phase of the disorder (Opal
et al., 1997; Abraham et al., 1998; van Dissel et al., 1998).
More recent findings indicate that, although in the beginning
of sepsis the balance favors an inflammatory profile (Powers
and Bubeck Wardenburg, 2014), anti-inflammatory responses
are initiated during the hyper-inflammatory phase leading to
subsequent immunosuppression (Tang et al., 2010; Boomer et al.,
2014). These varying states of immune paralysis are characterized
by impaired immune surveillance and the development of
persistent, recurrent, secondary, and nosocomial infections
which facilitate protracted events that often lead to death in
patients that have survived the initial period of sepsis (Monneret
et al., 2011; Otto et al., 2011).
The events that govern immunosuppression during sepsis
are not completely elucidated. Moreover, the role that TNF-
α signaling might have in modulating the anti-inflammatory
response has not been determined. Myeloid derived suppressor
cells (MDSC) have been described as an immature population of
cells that is able to suppress T cell responses in polymicrobial
sepsis and during chronic and persistent S. aureus infections
(Heim et al., 2014; Tebartz et al., 2015) and it has been
described that TNF-α participates in their accumulation and
activation during chronic inflammation (Sade-Feldman et al.,
2013). We have previously shown the ability of S. aureus to
modulate TNF-α/TNFR1 signaling during local and systemic
infections (Gómez et al., 2004; Giai et al., 2013). Therefore, we
hypothesize that TNFR1 signaling could have a role in directing
the immunosuppression during S. aureus sepsis and that MDSC
may participate in that response.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
S. aureus strain FPR3757 (pulsotype USA300, ST8, SCCmec type
IV-spa type 008, PVL positive) was provided by Dr. Alice Prince
(Columbia University, NY, USA). S. aureus strain Sa30 (ST30,
SCCmec type IVc-spa type 019, PVL positive) was previously
described (Fernandez et al., 2013). Bacteria were grown on
tryptone soy agar (TSA) or tryptone soy broth (TSB). Bacteria
were grown at 37◦C with agitation until an OD600 of 0.8: washed
and suspended in phosphate buffer (PBS).
Animals and Housing
Mice were obtained from andmaintained in the animal facility of
the Department of Microbiology, School of Medicine, University
of Buenos Aires. All the procedures involving laboratory animals
were approved by the Institutional Committee for Use and Care
of Laboratory Animal (CICUAL) of the School of Medicine,
University of Buenos Aires (Approval numbers 2737/14 and
2865/15) and followed internationally accepted guidelines
(National Institutes of Health, 1996). Animals were maintained
in a conventional facility, with controlled temperature (22 ±
1◦C), controlled humidity (55%), a 12:12 h light/dark cycle
and they were fed ad libitum. Procedures were performed in
an experimental room within the mouse facility. Mice were
euthanized using CO2. The number of mice required for each
experiment was determined based on preliminary experiments
and the desired statistical significance. Cumulative data from 2 to
4 independent experiments with small randomly chosen groups
(control and experimental groups) of 3 to 6 animals are shown.
The weight of the mice used was in accordance with their age.
They showed good mobility and no differences in behavior were
observed after manipulations. In this work molecular markers
were evaluated in live animals and postmortem. The levels of pro-
inflammatory cytokines in plasma from naïve mice were in the
range of expected basal levels (IL-6: 0–50 pg/ml; TNF-α: 0–100
pg/ml).
Mouse Model
C57BL/6 and TNFR1 deficient (tnfr1−/−) mice (6 weeks old,
18-20 grams) were intraperitoneally inoculated with 200 µl
of S. aureus containing 4 × 107 CFU. The control groups
were inoculated with PBS. Blood samples were obtained by
puncture of the mandibular vein at different times before and
after inoculation. Plasma was stored at −80◦C for subsequent
IL-10 and IL-6 quantification. The spleen was removed from
mice under sterile conditions and single-cell suspensions were
prepared by homogenization through a sterile stainless steel
mesh. To assess the bacterial load, aliquots of the infected spleen
were serial diluted and cultured on TSA plates.
In vivo Depletion of MDSC
Mice received a single intraperitoneal injection of 5′Fluorouracil
(5FU, 50 mg/kg), a dose proven to specifically deplete MDSC
without affecting other splenic cell populations (Vincent et al.,
2010; Poncini and González-Cappa, 2017), at day 4 post-
inoculation with S. aureus. MDSC depletion was confirmed by
flow cytometry analysis after staining spleen cells with antibodies
against CD11b, Gr-1, Ly6C, and Ly6G. Mice treated with
5FU evidenced Monocytic/Granulocytic MDSC proportions
equivalent to non-infected mice.
Flow Cytometry
Single-cell suspensions were incubated with fluorescently-labeled
mAbs for 30min at 4◦C. The following mAbs were used:
phycoerythrin-labeled anti-CD4, fluorescein isothiocyanate-
labeled anti-CD3 (Ligatis), allophycocyanin-labeled anti-CD8,
Alexa 488-labeled anti-Gr1, phycoerythrin-cyanin 7-labeled
anti-Gr1, phycoerythrin-labeled anti-CD11b, allophycocyanin-
labeled anti-Ly6G and phycoerythrin-cyanin 7-labeled anti-
Ly6G (Biolegend). Cells were washed and fixed in 1%
paraformaldehyde. For intracellular staining, cells were cultured
in the presence of monensin (2µM; Biolegend) for 5 h. After
surface staining, cells were incubated with phycoerythrin-labeled
anti-CD11b and phycoerythrin-cyanin 7-labeled anti-Gr1 for
30min at 4◦C. Then, the cells were fixed (4% PFA) and
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permeabilized (PBS, 0.5% saponin, 10% FBS). The Abs used
were anti-Arginase, anti-iNOS (Santa Cruz Biotechnology), and
Alexa488-labeled anti-rabbit IgG-Alexa (Invitrogen). For Foxp3
detection, cells were stained using the T regulatory (Treg)
cell detection kit (Miltenyi Biotec). Cells were acquired on a
FACSAria flow cytometer (BD Biosciences) and analyzed using
Cyflogic software.
Apoptosis
The percentage of lymphocytes undergoing apoptosis was
determined by flow cytometry using AnV (annexin V)-FITC
(Biolegend). The staining was performed according to the
manufacturer’s instructions.
MDSC Purification
Positive selection of Gr1+ cells was performed using microbeads
and MACS LS columns (Miltenyi Biotec), according to the
manufacturer’s protocol. Positively selected cells were passed
over a second selection column to increase their purity. Purity
of selected cells was >95% as verified by flow cytometry. Cell
viability was ≥95% as determined by Trypan blue exclusion.
In vitro Proliferation Assay
Splenocytes were labeled with carboxyfluorescein diacetate
succinimidyl ester (CFSE) according to the manufacturer’s
instructions (Biolegend). Following labeling, splenocytes were
cultured in RPMI medium supplemented with 2mM glutamine,
50µM 2-βME, 50µg/ml gentamicin and 10% FBS in triplicate in
round-bottomed 96-well plates at 2× 105 cell/well (100 µl/well).
Cells were cultured with 100 µl of complete medium or 100 µl
of complete medium containing concanavalin A (5µg/ml) for
72 h at 37◦C and 5% CO2. Cells were then harvested and the
supernatant was reserved to −20◦C for cytokine quantification.
Cells were stained with phycoerythrin-labeled anti-CD4 (Ligatis),
allophycocyanin-labeled anti-CD8 (Biolegend). The percentage
of CD4+ T cells and CD8+ T cells labeled with CFSE was
determined by flow cytometry.
In vitro Suppression Assay
Splenocytes from naïvemice were labeled with CFSE according to
the manufacturer’s instructions (Biolegend). Following labeling,
splenocytes were cultured with purified MDCS obtained from
the spleen of S. aureus inoculated mice in 1:0, 1:10, 1:20 (T
cells:MDSC) ratio in RPMI medium supplemented with 2mM
glutamine, 50µM 2-βME, 50µg/ml gentamicin and 10% FBS
in round-bottomed 96-well plates. Cells were cultured with
complete medium containing concanavalin A (5µg/ml) for
72 h at 37◦C and 5% CO2. Cells were then harvested and the
supernatant was reserved to −20◦C for cytokine quantification.
Cells were stained with phycoerythrin-labeled anti-CD4 (Ligatis),
allophycocyanin-labeled anti-CD8 (Biolegend). The percentage
of CD4+ T cells and CD8+ T cells labeled with CFSE was
determined by flow cytometry.
Real-Time Polymerase Chain Reaction
RNA was isolated using TRIzol Reagent (Invitrogen).
Complementary DNA (cDNA) was made from 1 µg of RNA
using M-MLV Reverse Transcriptase (Promega). The following
primers were used for amplification: for mouse Arginase,
5′-GTC CCT AAT GAC AGC TCC TTT C-3′ and 5′-CCA
CAC TGA CTC TTC CAT TCT T-3′; for mouse iNOS, 5′-CAC
AGC AAT ATA GGC TCA TCC A-3′ and 5′-GGA TTT CAG
CCT CAT GGT AAA C-3′; for mouse S100A8, 5′-GGA AAT
CAC CAT GCC CTC TAC AA-3′ and 5′-ATG CCA CAC CCA
CTT TTA TCA CC-3′; for mouse S100A9, 5′-GGA GCG CAG
CAT AAC CAC CAT C-3′ and 5′-GCC ATC AGC ATC ATA
CAC TCC TCA-3′ and for mouse glyceraldehyde-3-7phosphate
dehydrogenase (GAPDH), 5′-AAC TTT GGC ATT GTG GAA
GGG CTC-3′ and 5′-ACC CTG TTG CTG TAG CCG TAT
TCA-3′. GAPDH was used as a control for standardization.
ELISA
IL-10, IL-6, and IFN-γ were quantified by enzyme-linked
immunosorbent assay using matched antibody pairs (BD
Biosciences) according to the manufacturer’s instructions.
FIGURE 1 | Impact of TNFR1 signaling in the early events after the onset of S. aureus sepsis of peritoneal origin. Groups of C57BL/6 wild type and tnfr1−/− mice
were inoculated with S. aureus FPR3757 by intraperitoneal route. (A) The presence of bacteria in blood were monitored 4 h and 1 day post-inoculation. Bars represent
the percentage of mice with bacteriemia. (B) Weight loss were quantified at day 1 post-inoculation. (C) Plasma levels of IL-6 4 h post-inoculation were quantified by
ELISA. The levels of IL-6 before inoculation were below the detection limit (15 pg/ml). (B,C) Boxes and whiskers depict maximum and minimum values obtained from
individual mice and the horizontal line represents the median for each group. *p < 0.05, ***p < 0.001, compared with values obtained from the same group before
inoculation, Mann-Whitney U-test for nonparametric data. hpi: hours post-inoculation, dpi: days post-inoculation.
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FIGURE 2 | Impact of TNFR1 signaling on the local and systemic host
response during S. aureus sepsis of peritoneal origin. (A–F) Groups of
C57BL/6 wild type and tnfr1−/− mice were inoculated with S. aureus
FPR3757 (SA, gray bars and boxes), S. aureus Sa30 (Sa30, white bars) or
PBS (C, black bars) by intraperitoneal route. (A,B) Spleen weight (A) and
plasma levels of IL-10 (B) were determined at day 8 post-inoculation. IL-10
was not detected in plasma from mice inoculated with PBS. Boxes and
whiskers depict maximum and minimum values obtained from individual mice
and the horizontal line represents the median for each group. Dotted line in
(A) depicts median value of the PBS group (wild type and tnfr1−/− combined)
*p < 0.05, (a) p < 0.05, (b) p < 0.01, (c) p < 0.001, (a, b, c) compared with
the corresponding groups inoculated with PBS, Mann-Whitney U-test for
nonparametric data. (C,D) Bars represent the percentage of mice with CD4+
T cells that responded to ConA stimulation (less than 10% decrease in the
proliferative capacity compared with the control group). *p < 0.05, Fisher’s
exact test. (E) Splenocytes from mice inoculated with PBS were stimulated
with medium or ConA (5µg/ml). Bars represent the proliferative capacity of
CD4+ T cells in response to medium or ConA stimulation. ***p < 0.001,
Unpaired t-test. (F) Bars represent the percentage of mice with spleen
colonization at day 8 post-inoculation. *p < 0.05, Fisher’s exact test.
Statistical Analysis
When comparing two groups of data Student’s t-test or
the nonparametric Mann Whitney U-test were used based
on the data distribution. The proportions were analyzed
using Fisher’s exact test. The nonparametric correlation
Spearman test was used to analyze the correlation. All
the data collected from the experiments were included in
the analysis. A p-value < 0.05 was considered statistically
significant. GraphPad Prism software was used for statistical
analysis.
RESULTS
T Cell Anergy Induced by S. aureus Is
Dependent on TNFR1 Signaling
In order to understand the role of TNFR1 signaling in the events
that govern the immune dysfunction during S. aureus sepsis
we determined the proliferative capacity of splenic T cells in
the presence or absence of this receptor. The experiments were
conducted using a mouse model of S. aureus sepsis of peritoneal
origin (Ahn et al., 2006; Giai et al., 2013). In this model the
onset of sepsis was not dependent on TNFR1 signaling (Figure 1)
which allowed to determine the role of this receptor at a later
stage. Infection was characterized by a high rate of bacteriemia
4 h after the inoculation of S. aureus (Figure 1A). Bacteria were
present in blood 24 h later (Figure 1A) and cleared by day 4 (data
not shown). Significant weight loss was also observed at day 1
(Figure 1B) and a 10% of mortality that occurred during the first
48 h was recorded in both the wild type and the tnfr1−/− group.
In addition, significantly increased levels of IL-6, which have been
associated to the severity of sepsis in humans and animal models
(Hack et al., 1989; Borrelli et al., 1996; Remick et al., 2002), were
found in serum 4 h post-inoculation (Figure 1C).
At day 8 after inoculation, surviving mice developed
splenomegaly with a significant increase in the spleen mass
(Figure 2A) and increased levels of IL-10 in serum, characteristic
of the immunosuppressive phase of sepsis, were observed
(Figure 2B). Interestingly, the splenomegaly was significantly
lower in the absence of TNFR1 signaling (Figure 2A) and the
levels of circulating IL-10 were also reduced in this group
compared with wild type mice (Figure 2B). At this time point, a
significant proportion of wild type septic mice showed decreased
proliferative rates of CD4+ T cells (Figure 2C) whereas the
same population from septic tnfr1−/− mice was responsive to
Con A (Figure 2D). The impact of TNFR1 signaling on T cell
anergy did not depend on the staphylococcal strain used as
similar results were obtained using the Sa30 clinical isolate for
the induction of sepsis (Figures 2C,D). Moreover, we ruled out
potential differences in proliferation inherent to the TNFR1
signaling by comparing the ability of CD4+ T cells from wild
type and tnfr1−/− mice inoculated with PBS to proliferate in
response to ConA (Figure 2E). The increased functionality of
CD4+ T cells from TNFR1 deficient mice correlated with the
increased capacity of this group to clear bacteria from the
spleen (Figure 2F). Taken together these results indicate that
during staphylococcal sepsis CD4+ T cell anergy is significantly
dependent on TNFR1 signaling and it may have an impact on
bacterial burden in the spleen.
MDSC Modulate T Cell Activity During
Staphylococcal Sepsis
Several mechanisms have been proposed to account for T
cell dysfunction during sepsis. Among them are apoptosis of
T cells (Hotchkiss et al., 1999, 2001, 2002; Muenzer et al.,
2010), expansion of Treg (CD25+CD4+Foxp3+) cells (Hotchkiss
et al., 2013; Stieglitz et al., 2015) as well as the accumulation
of MDSC in peripheral organs (Sander et al., 2010; Cuenca
et al., 2011). The viability of CD4+ T cells in the spleen of
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FIGURE 3 | Mechanisms involved in T cell dysfunction during S. aureus sepsis. Groups of C57BL/6 wild type (A,B, D–F) and tnfr1−/− (C) mice were inoculated with
S. aureus FPR3757 (SA, gray circles) or PBS (C, black circles and bars) by intraperitoneal route and treated or not with 5FU (50 mg/Kg) (white bar) at day 4
post-inoculation by the same route. (A–C) The percentage of Annexin V-positive CD4+ T cells (A) and the percentage of Treg cells (CD4+CD25+Foxp3+)
(B,C) present in the spleen at day 8 post-inoculation were quantified. Each circle represents an individual mouse and the horizontal lines indicate the median value for
each group. *p < 0.05, Mann-Whitney U-test for nonparametric data. (D) Correlation analysis between the levels of IFN-γ produced by splenocytes of S. aureus
inoculated mice in response to ConA and the percentage of CD11b+Gr1+ cells present in the spleen of each mice at the time of splenocyte isolation. Each circle
represent an individual mouse. Data were analyzed using the Spearman test. (E) Percentage of MDSC present in the spleen at day 8 post-inoculation. *p < 0.05,
***p < 0.001, Mann-Whitney U-test for nonparametric data. (F) Bars represent the percentage of mice whose CD4+ T cells were able to respond to ConA stimulation
(less than 10% decrease in the proliferative capacity compared with the control group). Dotted line indicates the rate of CD4+ T cell response in mice inoculated with
SA and not treated with 5FU. (a) p < 0.05, compared with S. aureus inoculated mice not treated with 5FU; n.s. not significant, Fisher’s exact test.
infected wild type mice was equivalent to that of the control
group (Figure 3A) suggesting that apoptosis of T cells is not a
major process at this time point during staphylococcal infection.
A small increase in the percentage of Tregs was observed in
both wild type and tnfr1−/− mice at day 8 after inoculation
(Figures 3B,C) suggesting a minor role of this population in
the TNFR1-dependent T cell anergy. Then, we determined the
contribution of MDSC to the S. aureus-induced T cell anergy.
The levels of IFN-γ produced by splenocytes from wild type
infected mice in response to Con A, although they were very
variable among animals, showed significant inverse correlation
with the percentage of MDSC present in the spleen of wild
type septic mice (Figure 3D). To further confirm the role of
MDSC on the T cell dysfunction, the expansion of this population
was pharmacologically inhibited. Groups of wild type mice were
challenged with S. aureus and 5-Fluorouracil (5FU), and inducer
of MDSC death (Vincent et al., 2010), was administered by
intraperitoneal route 4 days later, a time at which bacteria had
already colonized the spleen and MDSC started to accumulate in
this organ (data not shown). As expected, the percentage and the
number of CD11b+Gr1+ cells in the spleen of mice treated with
5-FUwas significantly lower than that found in S. aureus infected,
non-treated mice and comparable to control non-infected mice
(Figure 3E and data not shown). In the absence of MDSC
accumulation the capacity of CD4+ T cells to proliferate in
response to Con A was restored (Figure 3F) indicating a major
role for MDSC in the generation of anergic CD4+ T cells during
S. aureus sepsis.
Accumulation of MDSC in the Spleen Is
Not Dependent on TNFR1 Signaling
After demonstrating that both TNFR1 signaling and MDSC are
critical in the induction of T cell anergy during staphylococcal
sepsis we evaluated the putative relationship between the
signaling mediated by this receptor and MDSC expansion
and accumulation in the spleen. A significant accumulation
of CD11b+Gr1+ cells in the spleen was observed at day 8
after the onset of sepsis in both wild type and tnfr1−/− mice
(Figures 4A,B). The absolute number of splenic CD11b+Gr1+
cells in septic mice was 6-fold the corresponding one in control
mice and increased levels of this population were still present
in the spleen at day 14 post-inoculation (Figure 4A). Septic
tnfr1−/−mice exhibited a similar pattern ofMDSC accumulation
in the spleen (Figure 4B) indicating that this process is
independent of TNFR1 signaling. The relative proportions of
cells with monocytic and granulocytic morphology among this
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FIGURE 4 | MDSC expansion and accumulation in the spleen during S. aureus sepsis. (A–D) Groups of C57BL/6 wild type (A,C) and tnfr1−/− (B,C) mice were
inoculated with S. aureus FPR3757 (SA, gray circles) or PBS (C, black circles) by intraperitoneal route. (A,B) The percentage and the absolute number of
(Continued)
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FIGURE 4 | CD11b+Gr1+ cells present in the spleen was determined at days 8 and 14 post-inoculation by staining with specific antibodies and flow cytometry
analysis. Representative dot plots and percentages of cells gated as CD11b+Gr1+ at day 8 post-inoculation are shown. (C) CD11b, Ly6G, and Ly6C expression was
determined in splenocytes at day 8 post-inoculation. Results were calculated after gating on the CD11b+ population. Representative dot plots of Ly6G and
Ly6C-stained cells and the quantitation of Mo-MDSC: Ly6ChighLy6G− and PMN-MDSC: Ly6ClowLy6G+ are shown. *p < 0.05, **p < 0.01, ***p < 0.001,
Mann-Whitney U-test for nonparametric data. The quadrants were placed according to the isotype controls. (D) Splenocytes from naive mice were co-cultured with
different proportions of CD11b+Gr1+ cells purified from S. aureus inoculated mice at day 8 post-challenge and stimulated with ConA (5µg/ml). Bars represent
proliferation of CD4+ T cells relative to that observed in the absence of MDSC (considered as 100%). *p < 0.05, ***p < 0.001, Unpaired t-test.
immature population was determined using the Ly6G and
Ly6C surface markers. Granulocytic MDSC were the prevalent
phenotype during infection in both wild type and tnfr1−/− mice
(Figure 4C). The suppressor phenotype of the MDSC expanded
and accumulated in the spleen in wild type and tnfr1−/− mice
during S. aureus infection was confirmed by determining their
capacity to suppress the proliferation of naïve T cells in response
to Con A in vitro (Figure 4D).
Purified MDSC from both wild type and tnfr1−/− mice
expressed similar levels of S100A8 and S100A9 (Figures 5A,B)
which have a known role in inflammation and directing
recruitment of this population (Cheng et al., 2008; Sinha
et al., 2008). This is in line with our results that indicate
that MDSC recruitment is not dependent of TNFR1 signaling.
Among the cytokines that have been proposed to induce MDSC
accumulation in tumors is IL-6 (Mundy-Bosse et al., 2011;
Tsukamoto et al., 2013; Chen et al., 2014). In the sepsis model, IL-
6 is early induced during infection (Figure 1C) (Giai et al., 2016)
and a significant correlation between the percentage of splenic
MDSC and the levels of circulating IL-6 at the onset of sepsis was
observed in both groups of mice (Figure 5C) suggesting that it
might be implicated in MDSC accumulation in the spleen.
TNFR1 Signaling Has an Impact in the
Expression of Immunomodulatory
Mediators by MDSC
After demonstrating that the T cell anergy observed during
staphylococcal sepsis was dependent on both, TNFR1 signaling
and MDSC, but the accumulation of MDSC in the spleen
of tnfr1−/− was equivalent to that of wild type mice
we hypothesized that TNFR1 signaling could modulate the
expression of immunosuppressive mediators in MDSC. These
cells are known to exert their suppressive function through the
expression of Arginase 1 and iNOS (Trikha and Carson, 2014;
Park et al., 2018). Therefore, we evaluated the expression of
these enzymes in MDSC purified from the spleen of wild type
and tnfr1−/− mice at day 8 after the onset of sepsis. MDSC
from wild type septic mice expressed both Arg-1 (Figure 6A)
and iNOS (Figure 6B). Conversely, expression levels of these
enzymes were low or undetectable in MDSC from tnfr1−/−
mice (Figures 6A,B). The expression of Arginase 1 and iNOS
in wild type mice at the protein level was confirmed by
intracellular staining and flow cytometry (Figures 6C,D). These
results indicate that whereas TNFR1 signaling is not required for
MDSC accumulation and expansion in the spleen, it determines
the in vivo expression of enzymes known to participate in the
suppressive function of this population.
FIGURE 5 | Role of TNFR1 in the accumulation of MDSC in the spleen.
Groups of C57BL/6 wild type and tnfr1−/− mice were inoculated with
S. aureus FPR3757 by intraperitoneal route. (A,B) MDSC were purified from
the spleen at day 8 post-inoculation. The relative expression levels of S100A8
(A) and S100A9 (B) mRNA in this population were determined by RT real-time
PCR and normalized to GAPDH. (a.u.): arbitrary units. Mann-Whitney U-test
for nonparametric data. (C) Correlation analysis between plasmatic levels of
IL-6 in C57BL/6 wild type (squares) and tnfr1−/− (circles) mice 4 h
post-inoculation and the percentage of MDSC present in the spleen at day 8
post-inoculation. Data were analyzed using the Spearman test.
Considering that MDSC from TNFR1 deficient mice showed
suppressive activity after in vitro culture in the presence of
ConA (Figure 4D), it is suggested that environmental factors
in the spleen that are modulated by TNFR1 could be involved
in the regulation of Arginase 1 and iNOS expression by MDSC
in vivo. Among the factors that could modulate MDSC activity
is IL-10 (Pinton et al., 2016; Chen et al., 2017). Therefore, we
determined the induction of IL-10 in the spleen of wild type
and TNFR1 deficient septic mice. S. aureus infection induced
IL-10 in both groups (Figure 7A). However, wild type mice
presented significantly increased levels of this cytokine in the
spleen compared with tnfr1−/− mice (Figure 7A). Treatment
with 5FU did not impact the overall production of IL-10
(Figure 7B) and the production of this cytokine was not detected
in purified MDSC from wild type mice (data not shown)
suggesting that although TNFR1 signaling was involved in the
induction of this cytokine in response to S. aureus, MDSC
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FIGURE 6 | Expression of immunosuppressive mediators by MDSC. Groups of C57BL/6 wild type (A–D) and tnfr1−/− (A,B) mice were inoculated with S. aureus
FPR3757 (SA, gray circles and bars) by intraperitoneal route. (A,B) The MDSC present in the spleen were purified at day 8 post-inoculation and the relative expression
of Arg-1 (A) and iNOS (B) in this population was determined by RT real-time PCR and normalized to GAPDH. (a.u.): arbitrary units. Mann-Whitney U-test for
nonparametric data. (C,D) The presence of Arginase and iNOS was determined by intracellular staining and flow cytometry in MDSC from wild type mice inoculated
with S. aureus or PBS (control). (C) 1MFI: Mean Fluorescence Intensity (MFI) infected - MFI control. (D) Representative histograms are shown.
are not the primary source of IL-10 in the spleen during
staphylococcal sepsis. To further investigate the role of IL-10
in the regulation of MDSC activity we quantified the levels
of this cytokine in the supernatant of the in vitro co-cultures
of MDSC from infected tnfr1−/− mice and näive splenocytes
stimulated with ConA as it was shown in Figure 4D. Stimulation
of splenocytes with ConA induced the production of IL-10 even
in the absence of TNFR1 signaling (Figure 7C) which could
explain the suppressive capacity of MDSC during the in vitro
co-culture experiments. Therefore, these results suggest that
TNFR1-mediated IL-10 production in response to S. aureus
infection may modulate MDSC function during staphylococcal
sepsis rather than TNFR1 direct signaling on MDSC.
DISCUSSION
S. aureus has emerged as a leading cause of sepsis (Powers
and Bubeck Wardenburg, 2014). Through improvements in
supportive care measures over the last few decades an increasing
percentage of the patients survive through the initial systemic
inflammatory period but a significant proportion of the patients
eventually succumb to late nosocomial infections (Cuenca and
Moldawer, 2012). The high mortality rate of sepsis and the
limited clinical success of multiple clinical trials aimed at
modulating the host immune response (Russell, 2006) indicate
that there is very limited understanding of the complex host-
pathogen interactions that take place during this pathology.
Although there is a growing consensus that late sepsis-associated
morbidities are related to global immunosuppression, the
multiple factors that drive the suppressive immune response are
not completely elucidated.
In the present study we demonstrated that TNFR1 signaling
is critically involved in the development of T cell anergy
during staphylococcal sepsis. To assure that this finding was not
unique to the infecting bacterial strain, we used two unrelated
isolates, the MRSA USA300 FPR3757 designated as sequence
type ST8 and highly epidemic in the United States (Planet,
2017) and the MRSA Sa30 designated as sequence type ST30,
the most prevalent clone isolated from invasive community
acquired staphylococcal infections in Argentina (Fernandez et al.,
2013). TNF-α has been previously linked to CD4+ T cell
anergy in HIV infection (Kaneko et al., 1997) and TRAFs,
signaling molecules downstream of TNFR1, have also been
implicated in defective T cell function (So et al., 2015). During
staphylococcal sepsis, CD4+ T cell anergy does not seem to be
the consequence of direct TNFR1 signaling on T cells because
their functionality could be recovered by blocking the expansion
of MDSC.
MDSC have been previously linked to T cell anergy and
bacterial persistence during chronic S. aureus infection (Heim
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FIGURE 7 | Impact of TNFR1 expression in the production of IL-10.
(A,B) Groups of C57BL/6 wild type (A,B) and tnfr1−/− (A) mice were
inoculated with S. aureus FPR3757 (SA, gray boxes and bars) by
intraperitoneal route and treated or not with 5FU (50 mg/Kg) (white box) at day
4 post-inoculation. IL-10 production in the spleen was quantified by ELISA.
Boxes and whiskers depict maximum and minimum values obtained from
individual mice and the horizontal line represents the median for each group.
*p < 0.05, (a) p < 0.05 (compared with wild type mice inoculated with PBS)
Mann-Whitney U-test for nonparametric data. (C) Splenocytes from naïve
tnfr1−/− mice were co-cultured with different proportions of CD11b+Gr1+
cells purified from tnfr1−/− mice inoculated with S. aureus and stimulated with
ConA (5µg/ml). Bars represent IL-10 levels in the supernatant at 72 h
post-stimulation. *p < 0.05, Mann-Whitney U-test for nonparametric data.
et al., 2014; Tebartz et al., 2015). Moreover, in recent studies
conducted with septic patients the expansion of granulocytic
MDSC correlated with bad prognosis of the disease regardless of
the microorganism involved (Mathias et al., 2017). Our results
further confirm that MDSC are major modulators of T cell
activity during staphylococcal sepsis. Moreover, T cell anergy
induced by S. aureus was accompanied by a heterogeneous
production of IFN-γ in the spleen and the levels of this cytokine
negatively correlated with the percentage of splenic MDSC.
This observation might be of clinical interest because it has
been shown that administration of IFN-γ reversed the adverse
sequelae of sepsis induced immunosuppression in patients
(Döcke et al., 1997).
Despite the increasing recognition of MDSC as key players in
modulating suppressive responses during infection there is very
little knowledge of themechanisms involved in their recruitment,
differentiation arrest and acquisition of the immunosuppressive
phenotype. TNF-α signaling mediates many of the systemic
inflammatory consequences of sepsis (Chousterman et al., 2017).
It is also critical for S. aureus clearance (Nakane et al., 1995;
Skabytska et al., 2014). Our results in the S. aureus sepsis model,
demonstrated that TNF-α signaling through TNFR1 is not
required for MDSC expansion and accumulation but it is critical
for the expression of MDSC immunosuppressive mediators such
as Arginase 1 and iNOS. A two signal model has been proposed
for the expansion and function of MDSC in which a first signal is
responsible for MDSC expansion and the second one for driving
MDSC activation (Condamine and Gabrilovich, 2011). During
chronic inflammation induced by mycobacterial antigens, TNF-
α exhibited a dual function arresting differentiation of immature
myeloid cells and augmenting MDSC activity (Sade-Feldman
et al., 2013). In tumors, it was proposed that TNF-α signaling
through TNFR2 inhibits caspase 8 activity and promotes MDSC
survival and accumulation helping tumor cells to evade the
immune system (Zhao et al., 2012). More recently the role
of TNFR2 in the generation of monocytic MDSC has been
demonstrated (Polz et al., 2014). TNFR2 signaling is mainly
driven bymembrane associated TNF-αwhereas TNFR1 signaling
is triggered by soluble TNF-α (Cabal-Hierro and Lazo, 2012). We
have previously demonstrated that S. aureus activates ADAM17,
the metalloprotease responsible of cleaving TNF-α from the cell
membrane. Moreover, in the sepsis model TNF-α expression is
induced in response to S. aureus inoculation (Giai et al., 2013).
Therefore, it is not unexpected that TNFR1 signaling will be
active during staphylococcal sepsis.
Interestingly, MDSC isolated from tnfr1−/− septic mice
showed intrinsic suppressive capacity when evaluated in vitro,
which suggests that mediators locally produced during infection
in a TNFR1-dependent manner could modulate their activity
in vivo. In line with this hypothesis, recent findings show that
locally produced IL-10 is implicated in MDSC activation in an
S. aureus biofilm infection model (Heim et al., 2015) and in
a collagen-induced model of rheumatoid arthritis (Park et al.,
2018). The data of our work indicate that during S. aureus
sepsis, TNFR1 signaling was critical for systemic and local IL-
10 induction. This finding could explain the lower expression of
Arginase 1 and iNOS, both known immunosuppressive factors, in
MDSC from tnfr1−/−mice compared withMDSC fromwild type
mice during in vivo infection. Therefore, the microenvironment
induced in response to the signaling cascades initiated by TNFR1,
which among other putative factors contains IL-10, could provide
the “second signal” and determine the activity of MDSC during
staphylococcal sepsis. In this regard, it has been established that
IL-10 levels are increased in septic patients and that those levels
predict mortality (Hotchkiss and Karl, 2003). The source of IL-
10 in the spleen were not the MDSC as this cytokine was not
detected in isolated MDSC and the levels of IL-10 were not
affected by blocking the expansion of this population. Thus, it
remains to be elucidated the population responsible for TNFR1-
dependent induction of IL-10.
Regarding the nature of the “first signal” driving the expansion
and accumulation of MDSC several studies have demonstrated
a positive relationship between increased proportions of MDSC
and higher levels of IL-6 (Trikha and Carson, 2014; Chen et al.,
2017). Our results show a positive correlation between the levels
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of IL-6 at early times after inoculation and the percentage of
MDSC accumulated in the spleen similarly to what it is observed
in septic patients in which a positive correlation between MDSC
and the levels of IL-6 at the day of admission was found (Darcy
et al., 2014).
In previous attempts to understand the events that dictate the
immunosuppression during sepsis, a role for Treg cells has been
proposed (Hotchkiss et al., 2013; Stieglitz et al., 2015). Moreover,
the capacity of MDSC in inducing the expansion of Tregs has
been demonstrated (Park et al., 2018). According to our study,
the Treg population seems to have, if any, a minor role in the
suppression of CD4+ T cell responses during staphylococcal
sepsis based on the observation that the expansion of these cells
did not correlate with either proper o defective TNFR1 signaling.
T cell anergy has now been largely recognized as an important
component of sepsis-related immunosuppression. However, the
signaling pathways induced by different bacterial pathogens that
lead to dampened T cell function are poorly understood. TNFR1
is a central player during S. aureus infections. This receptor
not only signals TNF-α, which is rapidly induced after the
entry of the bacteria, but it also recognizes protein A, a major
staphylococcal surface protein, initiating both pro-inflammatory
(Gómez et al., 2004, 2006) and anti-inflammatory cascades
(Giai et al., 2013, 2016). The results presented here indicate
that during staphylococcal sepsis TNFR1 has a significant
impact in modulating CD4+ T cell anergy and that function
of this receptor is relevant to bacterial clearance in the spleen.
Moreover, we demonstrated that TNFR1 signaling induces
the microenvironment to sustain MDSC suppressive activity
demonstrating the importance of this receptor during the
immunosuppressive phase of staphylococcal sepsis. Whether
TNFR1 signaling triggered by protein A, in addition to TNF-α,
is critical for MDSC activity remains to be elucidated.
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